2362.TW | Clevo Co. Annual & Quarterly Balance Sheets

Annual Balance Sheets

(In TWD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	94.42 Billion	94.16 Billion	91.29 Billion	94.26 Billion	100.38 Billion	112.45 Billion
Total Current Assets	17.83 Billion	17.05 Billion	15.85 Billion	15.25 Billion	21.6 Billion	25.59 Billion
Cash And Short Term Investments	10.22 Billion	9.25 Billion	6.35 Billion	8.36 Billion	10.74 Billion	13.86 Billion
Cash and Cash Equivalents	5.21 Billion	7.05 Billion	3.81 Billion	4.91 Billion	8.04 Billion	7.79 Billion
Short Term Investments	5 Billion	2.2 Billion	2.53 Billion	3.44 Billion	2.69 Billion	6.07 Billion
Net Receivables	3.68 Billion	2.57 Billion	3.42 Billion	2.24 Billion	5.78 Billion	2.31 Billion
Inventory	2.83 Billion	3.77 Billion	4.69 Billion	3.7 Billion	4.16 Billion	7.89 Billion
Other Current Assets	1.09 Billion	1.44 Billion	1.38 Billion	935.8 Million	920.04 Million	1.51 Billion
Total Non-Current Assets	76.58 Billion	77.11 Billion	75.44 Billion	79 Billion	78.77 Billion	86.86 Billion
Net PPE	5.91 Billion	8.09 Billion	6.69 Billion	9.23 Billion	10.28 Billion	9.97 Billion
Good Will And Intangible Assets	48.82 Million	57.95 Million	18.42 Million	30.7 Million	29.92 Million	21.31 Million
Good Will	10.33 Million	10.49 Million	10.33 Million	10.25 Million	10.27 Million	10.67 Million
Intangible Assets	38.49 Million	47.45 Million	8.08 Million	20.45 Million	19.65 Million	10.63 Million
Long-Term Investments	68.25 Billion	1.76 Billion	139.52 Million	27.74 Million	761.01 Million	-3.43 Billion
Tax Assets	729.55 Million	822.25 Million	387.32 Million	612.83 Million	181.79 Million	214.01 Million
Other Non Current Assets	1.64 Billion	66.37 Billion	68.2 Billion	69.09 Billion	67.51 Billion	80.1 Billion
Other Assets	-	-	-	-	-	-
Total Liabilities	53.24 Billion	52.37 Billion	49.98 Billion	54.38 Billion	60.59 Billion	70.6 Billion
Total Current Liabilities	17.5 Billion	16.11 Billion	13.76 Billion	17.81 Billion	21 Billion	19.06 Billion
Account Payables	2.97 Billion	2.42 Billion	2.74 Billion	2.09 Billion	1.89 Billion	1.85 Billion
Tax Payables	404.78 Million	418.27 Million	378.03 Million	189.55 Million	25.38 Million	170.19 Million
Short Term Debt	12.13 Billion	11.36 Billion	8.61 Billion	6.88 Billion	14.2 Billion	11.18 Billion
Deferred Revenue	44.98 Million	145.21 Million	1.88 Billion	1.76 Billion	2.86 Billion	170.19 Million
Other Current Liabilities	2.34 Billion	2.18 Billion	512.46 Million	7.07 Billion	2.03 Billion	5.85 Billion
Total Non Current Liabilities	35.73 Billion	36.26 Billion	36.22 Billion	36.57 Billion	39.59 Billion	51.53 Billion
Long-Term Debt	22.84 Billion	22.77 Billion	23.09 Billion	23.19 Billion	26.26 Billion	36.83 Billion
Deferred Revenue Non Current	111.83 Million	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1.21 Billion	1.21 Billion	1.12 Billion	1.17 Billion	1.25 Billion	2.32 Billion
Other Liabilities	-	-	-	-	-	-
Total Equity	41.18 Billion	41.79 Billion	41.31 Billion	39.87 Billion	39.79 Billion	41.85 Billion
Stock Holders Equity	41.18 Billion	41.79 Billion	41.31 Billion	39.87 Billion	39.79 Billion	41.83 Billion
Common Stock	6.32 Billion	6.32 Billion	6.49 Billion	6.69 Billion	6.69 Billion	6.79 Billion
Retained Earnings	3.66 Billion	2.61 Billion	3.14 Billion	1.11 Billion	1.1 Billion	1.54 Billion
Accumulated other comprehensive income	31.92 Billion	33.62 Billion	32.96 Billion	33.62 Billion	33.01 Billion	33.79 Billion
Common Stock Equity	41.18 Billion	41.79 Billion	41.31 Billion	39.87 Billion	39.79 Billion	41.83 Billion
Capital Lease Obligation	111.83 Million	345.92 Million	284.02 Million	112.26 Million	65.9 Million	-
Total Investments	73.26 Billion	3.97 Billion	2.67 Billion	3.47 Billion	3.45 Billion	2.63 Billion
Total Debt	35.09 Billion	34.14 Billion	31.71 Billion	30.07 Billion	40.46 Billion	48.02 Billion
Net Debt	29.88 Billion	27.09 Billion	27.89 Billion	25.15 Billion	32.41 Billion	40.23 Billion

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Total Assets	101.56 Billion	99.77 Billion	94.42 Billion	94.42 Billion	97.16 Billion	92.86 Billion
Total Current Assets	20.74 Billion	20.42 Billion	17.83 Billion	17.83 Billion	18.28 Billion	17.31 Billion
Cash And Short Term Investments	10.68 Billion	11.55 Billion	10.22 Billion	10.22 Billion	10.61 Billion	8.64 Billion
Cash and Cash Equivalents	4.95 Billion	5.41 Billion	5.21 Billion	5.21 Billion	6.49 Billion	5.55 Billion
Short Term Investments	5.73 Billion	6.14 Billion	5 Billion	5 Billion	4.11 Billion	3.09 Billion
Net Receivables	5.15 Billion	3.2 Billion	3.68 Billion	3.68 Billion	3.22 Billion	2.95 Billion
Inventory	3.91 Billion	4.12 Billion	2.83 Billion	2.83 Billion	3.03 Billion	4.14 Billion
Other Current Assets	991.88 Million	1.54 Billion	1.09 Billion	1.09 Billion	1.41 Billion	1.57 Billion
Total Non-Current Assets	80.82 Billion	79.34 Billion	76.58 Billion	76.58 Billion	78.88 Billion	75.54 Billion
Net PPE	6.09 Billion	6.07 Billion	5.91 Billion	5.91 Billion	8.37 Billion	7.92 Billion
Good Will And Intangible Assets	45.81 Million	45.5 Million	48.82 Million	48.82 Million	51.18 Million	53.59 Million
Good Will	10.87 Million	10.73 Million	10.33 Million	10.33 Million	10.7 Million	10.25 Million
Intangible Assets	34.93 Million	34.77 Million	38.49 Million	38.49 Million	40.48 Million	43.34 Million
Long-Term Investments	72.17 Billion	-2.12 Billion	68.25 Billion	68.25 Billion	-1.19 Billion	753.87 Million
Tax Assets	707.41 Million	713.48 Million	729.55 Million	729.55 Million	871.16 Million	845.1 Million
Other Non Current Assets	1.8 Billion	74.63 Billion	1.64 Billion	1.64 Billion	70.77 Billion	65.97 Billion
Other Assets	-	-	-	-	-	-
Total Liabilities	57.43 Billion	56.79 Billion	53.24 Billion	53.24 Billion	54.39 Billion	52.52 Billion
Total Current Liabilities	19.75 Billion	21.06 Billion	17.5 Billion	17.5 Billion	18.82 Billion	15.54 Billion
Account Payables	3 Billion	3.08 Billion	2.97 Billion	2.97 Billion	2.7 Billion	2.87 Billion
Tax Payables	369.14 Million	410.92 Million	404.78 Million	404.78 Million	285.31 Million	258.32 Million
Short Term Debt	13.22 Billion	14.52 Billion	12.13 Billion	12.13 Billion	14.07 Billion	9.78 Billion
Deferred Revenue	52.29 Million	2.78 Billion	44.98 Million	44.98 Million	1.59 Billion	2.42 Billion
Other Current Liabilities	3.47 Billion	662.93 Million	2.34 Billion	2.34 Billion	443.14 Million	456.47 Million
Total Non Current Liabilities	37.67 Billion	35.73 Billion	35.73 Billion	35.73 Billion	35.57 Billion	36.97 Billion
Long-Term Debt	24.31 Billion	22.47 Billion	22.84 Billion	22.84 Billion	21.63 Billion	23.64 Billion
Deferred Revenue Non Current	71.52 Million	-	111.83 Million	111.83 Million	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1.23 Billion	1.19 Billion	1.21 Billion	1.21 Billion	1.26 Billion	1.21 Billion
Other Liabilities	1.00	-	-	-	-	-
Total Equity	44.13 Billion	42.97 Billion	41.18 Billion	41.18 Billion	42.76 Billion	40.34 Billion
Stock Holders Equity	44.13 Billion	42.97 Billion	41.18 Billion	41.18 Billion	42.76 Billion	40.34 Billion
Common Stock	6.32 Billion	6.32 Billion	6.32 Billion	6.32 Billion	6.32 Billion	6.32 Billion
Retained Earnings	3.04 Billion	3.51 Billion	3.66 Billion	3.66 Billion	3.45 Billion	3.2 Billion
Accumulated other comprehensive income	35.45 Billion	33.86 Billion	31.92 Billion	31.92 Billion	33.72 Billion	31.55 Billion
Common Stock Equity	44.13 Billion	42.97 Billion	41.18 Billion	41.18 Billion	42.76 Billion	40.34 Billion
Capital Lease Obligation	71.52 Million	200.23 Million	111.83 Million	111.83 Million	262.67 Million	286.46 Million
Total Investments	77.9 Billion	4.01 Billion	73.26 Billion	73.26 Billion	2.91 Billion	3.84 Billion
Total Debt	37.6 Billion	37 Billion	35.09 Billion	35.09 Billion	35.71 Billion	33.42 Billion
Net Debt	32.65 Billion	31.59 Billion	29.88 Billion	29.88 Billion	29.21 Billion	27.87 Billion

Balance Sheet Charts

Alltop Technology Co., Ltd.

3526

Full Analysis

Annual Balance Sheets
Reve Technologies, Inc.

BSSP

Full Analysis

Annual Balance Sheets
Vera Therapeutics, Inc.

VERA

Full Analysis

Annual Balance Sheets
DiaMedica Therapeutics Inc.

DMAC

Full Analysis

Annual Balance Sheets
Zvi Sarfati & Sons Investments & Constructions Ltd.

SRFT

Full Analysis

Annual Balance Sheets
Fortune Oriental Company Limited

2491

Full Analysis

Annual Balance Sheets

Global Stocks Search

Clevo Co. (2362.TW)

Annual Balance Sheets

Balance Sheet Charts

Alltop Technology Co., Ltd.

Reve Technologies, Inc.

Vera Therapeutics, Inc.

DiaMedica Therapeutics Inc.

Zvi Sarfati & Sons Investments & Constructions Ltd.

Fortune Oriental Company Limited